• AB Science and University of Chicago to develop Covid-19 drugs pharmaceutical-technology
    April 08, 2021
    AB Science and the University of Chicago (UC) have signed an exclusive licensing agreement to carry out research on Covid-19 prevention and treatment with the former’s oral drug, masitinib and other drugs.
PharmaSources Customer Service